• 应用纪要

ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System: Analytical Performance for Androgens, Progestogens and Glucocorticoids

ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System: Analytical Performance for Androgens, Progestogens and Glucocorticoids

  • Waters Corporation

For in vitro diagnostic use. Not available in all countries.

Introduction

The Waters ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System enables the quantification of organic compounds in human biological liquid matrices.

This document describes a test of the analytical performance of the ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System for the analysis of testosterone, androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate, cortisol, 11-deoxycortisol, and 21-deoxycortisol in serum.

ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System
ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System.

Experimental

The ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System was controlled by MassLynx IVD Software (v4.1) and the data processed using the TargetLynx Application Manager. Calibrators and Quality Controls were prepared by spiking commercially available reference material in stripped serum and the samples were processed using the following conditions:

Sample Description

100 μL sample was precipitated with methanol, diluted with water, and centrifuged. Samples were loaded on Oasis PRiME HLB μElution plates, washed, and eluted prior to analysis.

LC Conditions

Column:

ACQUITY UPLC HSS T3 (IVD) 1.8 μm, 2.1 × 50 mm

Pre-column:

VanGuard HSS T3 1.8 μm, 2.1 × 5 mm

Mobile phase A:

2 mM Ammonium acetate +0.1% formic acid in water

Mobile phase B:

2 mM Ammonium acetate +0.1% formic acid in methanol

Flow rate:

0.6 mL/min

Gradient:

45% B over one minute, 45–65% B over 2.5 minutes, 98% B for 0.5 minutes

MS Conditions

Resolution:

MS1 (0.75 FWHM), MS2 (0.75 FWHM)

Acquisition mode:

MRM

Polarity:

ESI (+/-)

Results and Discussion

Analytical selectivity of the chromatographic separation is illustrated in Figure 1. Performance characteristics of the steroid hormones on the ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System are shown in Table 1.

 Chromatographic selectivity of a range of steroids using the ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System
Figure 1. Chromatographic selectivity of a range of steroids using the ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System.
 Performance characteristics of the analytes evaluated

Table 1. Performance characteristics of the analytes evaluated. Range defined by linear fit where r2 >0.99. LLOQ defined by S/N (PtP) >10 and %RSD <20%. %RSD at LLOQ determined through analytical sensitivity experiments performed over three occasions (n=30). Total precision and repeatability of QCs performed over five occasions in stripped serum (n=25). EQA mean bias determined through Altman-Bland comparison of calculated concentrations to EQA mass spectrometry mean values.

Note: To convert SI units to conventional mass units divide by 3.470 for testosterone (nmol/L to ng/mL), 3.494 for androstenedione (nmol/L to ng/mL), 3.028 for 17-OHP (nmol/L to ng/mL), 2.716 for DHEAS (nmol/L to ng/mL), 2.761 for cortisol (nmol/L to ng/mL), and 2.889 for 11-deoxycortisol and 21-deoxycortisol (nmol/L to ng/mL).

Conclusion

The Waters ACQUITY UPLC I-Class/Xevo TQ-S micro IVD System has demonstrated the capability to deliver analytically sensitive, selective performance with excellent precision, and accuracy for testosterone, androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate, cortisol, 11-deoxycortisol, and 21-deoxycortisol in serum.

Disclaimer

The analytical performance data presented here is for illustrative purposes only. Waters does not recommend or suggest analysis of the analytes described herein. These data are intended solely to demonstrate the performance capabilities of the system for analytes representative of those commonly analyzed using liquid chromatography and tandem mass spectrometry. Performance in an individual laboratory may differ due to a number of factors, including laboratory methods, materials used, intra-operator technique, and system conditions. This document does not constitute a warranty of merchantability or fitness for any particular purpose, express or implied, including for the testing of the analytes in this analysis.

720006266, August 2018

返回顶部 返回顶部